强的松
医学
醋酸阿比特龙酯
肿瘤科
内科学
危险系数
前列腺癌
中期分析
化疗
泌尿科
外科
癌症
雄激素剥夺疗法
胃肠病学
随机对照试验
置信区间
作者
Charles J. Ryan,Matthew R. Smith,Johann S. de Bono,Arturo Molina,Christopher J. Logothetis,Paul de Souza,Karim Fizazi,Paul N. Mainwaring,Josep M. Piulats,Siobhan Ng,Joan Carles,Peter F.A. Mulders,Ethan Basch,Eric J. Small,Fred Saad,Dirk Schrijvers,Hendrik Van Poppel,Som D. Mukherjee,H. Suttmann,Winald R. Gerritsen
标识
DOI：10.1056/nejmoa1209096
摘要
Abiraterone improved radiographic progression-free survival, showed a trend toward improved overall survival, and significantly delayed clinical decline and initiation of chemotherapy in patients with metastatic castration-resistant prostate cancer. (Funded by Janssen Research and Development, formerly Cougar Biotechnology; ClinicalTrials.gov number, NCT00887198.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Criminology34
yyds
ceeray23
进击的PhD
Haoru
sxb10101
AneyWinter66
大龙哥886
xu
null
叽了咕噜
咕哒猫
若宫伊芙
tuanheqi
yipinghao
无极微光
hyf
6666
清飏
浮游
归去来兮
Mic
Twonej
竹筏过海
皖公网安备34019202002308
